Muhammad Marsha Azzami Hasibuan

Mr. Muhammad Marsha Azzami Hasibuan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
Gusnia Meilin GholamGusnia Meilin Gholam
Gusnia Meilin Gholam
RIRiyan Alifbi Putera Irsal
Riyan Alifbi Putera Irsal
MDMaheswari Alfira Dwicesaria
Maheswari Alfira Dwicesaria
MHMuhammad Marsha Azzami Hasibuan
Muhammad Marsha Azzami Hasibuan
Malaria is one of the infectious illnesses causing a public health burden worldwide. Plasmodium vivax (P. vivax) is the most prevalent malaria parasite in Asia and Asia Pacific. P. vivax is resistant to sulfadoxine–pyrimethamine (SP) and mefloquine. This resistance makes it extremely difficult to control and eradicate due to its ability to survive in the liver and reactivate if the person infected has a weakened immune system. Thus, this study aims to inhibit P. vivax via targeting Duffy-binding protein (DBP) with active compounds from Hops (Humulus lupulus). The inhibition of DBP is essential to reduce malaria invasion of human red blood cells. We performed a quality assessment and prediction of the active site of DBP to determine the effectiveness and prediction of ligands in inhibiting DBP. Furthermore, the mechanism and structural stability of active compounds against DBP were evaluated using a combination of molecular docking and molecular dynamics simulation and a density-functional theory (DFT) study. The results showed that rutin had the highest binding of 8.852 kcal/mol. However, after the molecular dynamics simulation was run for 50 ns, the ligand 6-prenylnaringenin via MM-PBSA calculation showed the most positive value of 106.760 kJ/mol. In addition, 6-prenylnaringenin is the most stable ligand via the analysis of root-mean-square deviation backbone (RMSDBb), root-mean-square deviation c-alpha (RMSDCa), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), radius of gyration (Rg), and the hydrogen bond formation. We conclude that 6-prenylnaringenin has a tight and stable bond with the targeted DBP protein. Finally, we propose the use of 6-prenylnaringenin as a potential antimalarial compound via in silico studies.

15 August 2026 in Biointerface Research in Applied Chemistry
Verified
Journal Article
Open access
MHMuhammad Marsha Azzami Hasibuan
Muhammad Marsha Azzami Hasibuan
FPFarel Immanuel W. Purba
Farel Immanuel W. Purba
LMLaila Rahmah Maulidyani
Laila Rahmah Maulidyani
SRSyahida Zulfa Raihani
Syahida Zulfa Raihani
Allergies represent a significant global health concern, manifesting when allergens cross-link immunoglobulin E (IgE) bound to high-affinity FcεRI receptors on mast cells, triggering the release of the inflammatory mediators responsible for allergic symptoms. Synthetic antihistamines have been shown to be effective in reducing allergy symptoms, but they are associated with potent side effects. Natural antihistamines derived from plant secondary metabolites have attracted attention for their potential efficacy and fewer side effects. Sungkai (Peronema canescens) leaves contain bioactive compounds that can act as natural antihistamines. The study is supplemented by consideration of reports on additional properties with potential application in structure-activity relationships (SAR) research for the development of therapeutic drugs, as well as bioactivity radars related to the drug-like behavior of the studied compounds. Based on the results of Lipinski’s rule of 5 and ADMET pharmacokinetic screening, followed by molecular screening of the histamine 1 receptor, two compounds with potential antihistamine activity were obtained. The compounds were DTXSID80244086 and Genkwanin. DTXSID80244086 has a strong binding energy of 8.36 kcal/mol but does not interact with key sites on the H1 Receptor. The second compound, Genkwanin, has more potential as an antihistamine due to its binding energy, which is competitive with Loratadine (8.35 vs 6.31 kcal/mol) but lower than Doxepin (8.35 vs 11.53 kcal/mol). DFT results showed that both DTXSID80244086 and Genkwanin have potential as drug-like molecules. Based on these results, it can be concluded that genkwanin can serve as an alternative histamine H1 receptor inhibitor, replacing Doxepin and Loratadine, the latest generation of antihistamine drugs.

15 August 2026 in Biointerface Research in Applied Chemistry
Verified
Journal Article
Open access
RSRADEN HARYO BIMO SETIARTO
RADEN HARYO BIMO SETIARTO
MHMuhammad Marsha Azzami Hasibuan
Muhammad Marsha Azzami Hasibuan
DADimas Andrianto
Dimas Andrianto
Bioactive compounds derived from medicinal plants have attracted considerable scientific interest because of their diverse biochemical properties and potential antioxidant-related activities. Peronema canescens is traditionally used in herbal medicine and contains phytochemical constituents with potential biological activity. In this study, an in silico approach was used to evaluate bioactive compounds from sungkai leaves for their potential to modulate superoxide dismutase (SOD) allosterically. This important antioxidant enzyme protects against oxidative stress. The study included Lipinski screening, bioavailability prediction, toxicity prediction, and molecular docking analysis targeting the predicted allosteric region of SOD. In addition, global and local chemical reactivity descriptors and bioactivity-related properties were analyzed to support preliminary structure–activity relationship (SAR) assessment. Among the screened compounds, CHEMBL1407860 demonstrated acceptable predicted pharmacokinetic and toxicity profiles. It showed a higher docking score at the predicted allosteric site of SOD than D-trehalose (6.128 kcal/mol vs 5.183 kcal/mol) within the YASARA scoring framework. Residue-interaction analysis indicated potential binding interactions near the enzyme's predicted allosteric region. However, these findings are based solely on computational prediction and do not confirm enzymatic activation or therapeutic efficacy. Therefore, CHEMBL1407860 may be considered a computationally prioritized candidate for further investigation as a possible SOD allosteric-binding compound. Additional molecular dynamics simulations, biochemical enzyme assays, and cellular studies are required to validate its biological activity and mechanism of action.

30 June 2026 in Letters in Applied NanoBioScience
Verified
Journal Article
Open access
MHMuhammad Marsha Azzami Hasibuan
Muhammad Marsha Azzami Hasibuan
DADimas Andrianto
Dimas Andrianto
RSRADEN HARYO BIMO SETIARTO
RADEN HARYO BIMO SETIARTO
Peronema canescens Jack, commonly known as Sungkai, is native to Southeast Asia and traditionally used in ethnomedicine to treat fever, infections, and inflammatory disorders. This study evaluated the antioxidant and antibacterial activities of Sungkai leaves and quantified their bioactive compounds. This study employed TPC (Total Phenolic Content), TFC (Total Flavonoid Content), DPPH (2,2-diphenyl-1-picrylhydrazyl), and FRAP (Ferric Reducing Antioxidant Power) methods to assess the antioxidant ability, as well as MIC (Minimum Inhibitory Concentration) and MBC (Minimum Bactericidal Concentration) methods to evaluate the antibacterial ability. Total phenolic content (TPC) was 112.5 ± 3.4 mg GAE/g, and total flavonoid content (TFC) was 87.2 ± 2.8 mg QE/g. Antioxidant activity measured by DPPH and FRAP assays showed an IC50 of 48.6 ± 1.7 µg/mL and a FRAP value of 510 ± 15 µM Fe²⁺/g, indicating strong antioxidant potential. Antibacterial activity, assessed via MIC and MBC, was weak, with MIC and MBC values exceeding 10,000 ppm for all tested fractions. These results suggest that Sungkai leaves are a promising source of natural antioxidants, although their antibacterial efficacy is limited.

15 February 2026 in Biointerface Research in Applied Chemistry
Verified
Journal Article
Open access
MHMuhammad Marsha Azzami Hasibuan
Muhammad Marsha Azzami Hasibuan
DADimas Andrianto
Dimas Andrianto
RSRADEN HARYO BIMO SETIARTO
RADEN HARYO BIMO SETIARTO
Reactive oxygen species (ROS) are highly reactive molecules produced during normal metabolism that can cause oxidative stress when accumulated. Catalase (CAT) is a key antioxidant enzyme that decomposes hydrogen peroxide into water and oxygen, maintaining cellular redox balance. This study investigated bioactive compounds from Peronema canescens (Sungkai) leaves as potential allosteric activators of catalase using an integrated in silico approach. Forty-three phytochemicals were evaluated through ADMET profiling, toxicity prediction, and molecular docking against the catalase allosteric site. Global and local reactivity descriptors, structure–activity relationships (SAR), and bioactivity radar analyses were applied to assess drug-likeness and pharmacological potential. Among the tested ligands, SMR000036195 (2-oxo-6-(piperidin-1-sulfonyl)-benzothiazole-3-carboxylic acid isobutyl ester) exhibited the strongest binding affinity (–7.63 kcal/mol), surpassing the reference activator D-trehalose (–6.07 kcal/mol). The compound also demonstrated favourable pharmacokinetic and safety profiles, suggesting low toxicity and good bioavailability. Key residue interactions indicated stable allosteric binding that may enhance catalase activity through conformational modulation. These findings propose SMR000036195 as a promising natural allosteric activator of catalase, potentially contributing to the development of antioxidant therapies targeting oxidative stress–related disorders. Further in vitro and in vivo studies are warranted to validate its enzyme activation and therapeutic potential.